SeaBeLife is a biotechnology company developing two families of patented candidate molecules designed to block regulated necrosis – also known as regulated cell death.

Our therapeutic solution has demonstrated, in vitro and in multiple in vivo proofs-of-concept, to be able to simultaneously block two forms of regulated cell death and thus protect organs under attack from disease.